文献速递瓣膜外科

二尖瓣人工瓣膜患者- prosthesis 不匹配对肺动脉高压的影响

Effect of prosthesis patient mismatch in mitral position on pulmonary hypertension.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

PPM定义为指数化有效瓣口面积≤1.2 cm²/m²,发生率为37.2%。PPM组术后肺动脉高压消退率更低、远期生存更差,PPM是持续性肺动脉高压的独立预测因子。

要点

  • 二尖瓣PPM发生率为37.2%,定义为指数化有效瓣口面积≤1.2 cm²/m²。
  • PPM组术后PASP更高(42.35 vs 30.49 mmHg,P<0.001),肺动脉高压消退率更低(20.64% vs 76.26%)。
  • PPM与远期生存率降低独立相关,倾向性评分匹配后结论一致。

核心结论

  • 二尖瓣PPM是二尖瓣置换术后持续性肺动脉高压的独立预测因子,并与并发症增加和生存率降低相关。

研究设计与样本

  • 术后6个月通过多普勒超声心动图测量肺动脉收缩压,与术前值比较。
  • 构建多变量模型确定肺动脉收缩压的独立决定因素,并构建倾向性评分模型平衡PPM组与无PPM组的基线差异。

主要发现

  • PPM发生率为37.2%。
  • 无PPM组与PPM组术后平均肺动脉收缩压分别为30.49 mmHg和42.35 mmHg(P<0.001)。
  • PPM组与无PPM组肺动脉高压消退率分别为76.26%和20.64%(P<0.001)。
  • 指数化有效瓣口面积与术后肺动脉收缩压良好相关(r=0.71)。
  • 总体生存率和免于心脏死亡在10年分别为79.8%和85.3%,在20年分别为66.5%和74.3%;无PPM组均高于PPM组(P<0.001)。

关键数值与推荐

  • 肺动脉高压定义为肺动脉收缩压≥40 mmHg。
  • PPM定义为指数化有效瓣口面积≤1.2 cm²/m²。

临床怎么用

  • 二尖瓣置换术中应关注瓣膜-患者不匹配,选择有效瓣口面积足够的瓣膜以降低术后持续性肺动脉高压风险。
  • 术后6个月应通过超声心动图评估肺动脉收缩压,识别PPM相关肺动脉高压持续者。

局限性

  • 本研究为回顾性设计。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pulmonary arterial hypertension (PAH) is associated with poor outcome after mitral valve replacement (MVR). We proposed to evaluate the effect of valve prosthesis patient mismatch (PPM) on pulmonary arterial (PA) pressure following MVR. METHODS: Five hundred patients who have undergone MVR were studied retrospectively. Postoperative PA systolic pressure (PASP) measured 6 months postoperatively by Doppler echocardiography was compared with preoperative values. PASP ≥ 40 mmHg was defined as PAH. Mitral valve effective orifice area was calculated by the continuity equation and indexed for body surface area. PPM was defined as indexed effective orifice area ≤ 1.2 cm2/m2. A multivariate model was constructed to ascertain the independent determinants of systolic PA pressure. Also, a propensity score model was constructed to overcome the baseline differences between the PPM and no PPM groups. RESULTS: The incidence of PPM in this study was 37.2%. The average postoperative PASPs were 30.49 and 42.35 mmHg in the no PPM and PPM groups, respectively; (P < 0.001). Regression of PAH in the PPM and no PPM groups was 76.26% and 20.64%, respectively; (P < 0.001). The indexed effective orifice area correlated well with postoperative PASP (r = 0.71). The overall survival and freedom from cardiac death at 10 years were 79.8% and 85.3%; and at 20 years were 66.5% and 74.3%, respectively. Both, overall survival and the freedom from cardiac death were higher in the no PPM group than in the PPM group; (P < 0.001). Propensity score matching analysis yielded 112 pairs of the PPM and no PPM cohorts, which revealed higher overall survival and freedom from cardiac death in the no PPM group; (P = 0.028 and 0.012, respectively). CONCLUSIONS: Mitral PPM is an independent predictor of persistent PAH after MVR along with associated morbidity and reduced survival.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Ammannaya GKK, Mishra P, Khandekar JV, et al. Effect of prosthesis patient mismatch in mitral position on pulmonary hypertension. Eur J Cardiothorac Surg. 2017. PMID: 28591821. doi:10.1093/ejcts/ezx167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。